Company / Depreciation & Amortization
Enveric Biosciences, Inc. Depreciation & Amortization History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$2.9M
FY2019
5-year range
$1.4M / $3.2M
FY2017-FY2019
Trend
-9.7%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $1M to $3M over the past 2 years.
Based on SEC 10-K filings.
$3M in FY2019.
Increased from $1M to $3M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, depreciation & amortization decreased 9.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $2.9M | -9.7% |
| FY2018 | $3.2M | +136.4% |
| FY2017 | $1.4M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026